Loading...
Summary
Male erectile dysfunction (ED) has a prevalence of roughly 16–17% in men over 40, yet only about 10% seek medical help. Shame, fear of pain, and uncertainty about efficacy are the three main barriers to care. This article uses the European EAU guideline, LI-SWT systematic reviews, and Liusmed Clinic's treatment-room-clear protocol as its anchors to explain the evidence boundaries, process design, and risk disclosure of shockwave + PRP — helping you make an informed decision.
This article does not promise specific outcomes, nor does it replace physician consultation. EAU currently lists PRP for ED as having insufficient evidence, recommended only in clinical-trial settings. We take the conservative position — placing the focus on process quality and comfort, not on efficacy claims.
Why "Shame" Is the Biggest Barrier
Statistics from Taiwan's EDACT (Erectile Dysfunction Diagnosis and Counseling Center) show that among ED patients, only 10% seek medical help, and 75% of diagnosed patients choose not to be treated. A large portion of posts on PTT and Dcard begin with "asking for a friend" — reflecting significant resistance to care.
Three major anxieties observed on forums:
Fear of being recognized: awkwardness in the waiting area and from nursing staff coming in and out of the treatment room
Fear of being upsold: difficulty distinguishing medical recommendations from commercial pitches
Fear of not being able to tell one's partner: partner pressure is the most common push toward care, but bringing it up is extraordinarily difficult
Liusmed Clinic's response isn't a "privacy slogan" — it's an executable SOP: the treatment-room-clear protocol (see Section 6).
Low-Intensity Shockwave (LI-SWT): What the EAU Guideline Says
2.1 Guideline Position
The European Association of Urology (EAU), in its Sexual and Reproductive Health guideline, lists LI-SWT as a treatment option for mild vasculogenic ED, with a weak recommendation, requiring:
• Full disclosure to patients that "evidence is still accumulating"
• Case-by-case evaluation rather than fixed packages
• Avoid LI-SWT as monotherapy for severe or psychogenic ED
2.2 What Systematic Reviews Say
Campbell JD et al., in Translational Andrology and Urology (2019), synthesized multiple LI-SWT randomized controlled trials and concluded:
> LI-SWT may bring IIEF-5 score improvement in mild vasculogenic ED, but energy density, pulse count, protocol cadence, and probe shape vary significantly across clinical trials — no standardized protocol has emerged.
Another review, by Chung E & Wang J in Expert Review of Medical Devices (2021), added a critical clinical fact:
> Pain is one of the practical factors clinically limiting energy escalation.
This statement is the literature basis for our "comfort → complete the protocol" causal logic — not the claim that "higher energy is better" (no current evidence supports that), but the observation that "insufficient comfort forces physicians to reduce energy or discontinue treatment."
2.3 Reasonable Patient Expectations
Based on this evidence, reasonable expectations are:
• May improve, not a guaranteed improvement
• Individual variation is large; IIEF-5 tracking as an objective metric
• Not permanent; requires periodic reassessment
• Not appropriate as sole therapy for severe ED
PRP Injection: Why Guidelines Remain Conservative
3.1 EAU's Explicit Position
EAU's assessment of PRP for intracavernosal injection: evidence insufficient; recommended only in clinical-trial settings. This is an important compliance and ethical signal — any commercial website claiming PRP as standard ED therapy is overclaiming.
Liusmed Clinic's stance:
• PRP is a complementary option, not ED monotherapy
• Before each procedure, we disclose EAU's evidence limitations in writing
• Preparation parameters, injection layers, and doses follow standardized documentation and are transparent to the patient
3.2 The Precise Definition of "Low-Discomfort PRP"
Market claims of "painless PRP" warrant careful interpretation. Our definition:
• Low-discomfort protocol: local anesthesia with buffering technique to reduce sharp pain
• Not absolutely painless: a 27G needle can still cause transient discomfort or bruising
• Individual variation: some patients report minimal sensation; some report mild discomfort
Why does "low-discomfort protocol" matter? Because injection pain affects subsequent treatment willingness, which affects protocol completeness — this is the foundational logic of our third major advantage.
The "Triangle" Causal Chain
Liusmed Clinic's three differentiating advantages form a single narrative:
Key clarification: this causal chain describes process quality — not a claim that "privacy / painlessness = better efficacy." Efficacy still depends on each patient's vascular, neurological, and endocrine status, and on clinical judgment.
Who Is Suitable? Who Is Not?
5.1 Potentially Suitable
• Mild to moderate vasculogenic ED
• Unwilling to rely long-term on oral medications, or with contraindications
• Partner relationship affected by sexual performance, willing to evaluate jointly
• Mixed stress-type presentation and vasculogenic factors
5.2 Not Suitable (Contraindications)
• Severe coagulopathy or on anticoagulants
• Active infection in the treatment area
• Penile implant, active Peyronie's disease, chronic corporal pathology
• Active malignancy
• Assessed as purely psychogenic ED (psychological medical intervention is primary)
Important: any assessment must be synthesized by a physician based on history, IIEF-5, and necessary vascular and endocrine investigations. Online self-assessment checklists do not replace clinical evaluation.
Treatment-Room Privacy SOP
This is our most specific privacy commitment. A precise distinction is needed:
> "Treatment-room clear" ≠ "whole-clinic clear"
We don't shut down the entire clinic — we ensure, for your treatment room specifically:
6.1 Three-Stage Protocol
LINE anonymous consultation: ask 3 questions anonymously via LINE — no real name or ID required. After determining suitability, decide whether to schedule.
Independent on-site flow: upon arrival at the appointment time, directly enter the consulting room without passing through general waiting areas — minimizing encounters with other patients.
Treatment-room clear: during evaluation and treatment, only the male physician is in the treatment room performing the procedure; no nursing staff enter the room. Other clinic services run in parallel.
6.2 Why Not Shut Down the Whole Clinic?
This is an honest trade-off:
• Whole-clinic shutdown affects other patients' access to care — not consistent with medical ethics
• Treatment-room-level clearing already addresses the core anxiety of "having a third party present during the procedure"
• Keeping the clinic operational lets us maintain medical quality and emergency response capability
6.3 VIP Appointment Windows
For patients wanting additional privacy protection (e.g., full buffer times before and after), VIP appointments are available. The VIP premium reflects the extra staff and flow arrangements; we disclose this transparently at booking — no forced upgrade.
Treatment Flow (Five Stages)
Important: not every patient needs PRP combined. Whether to combine, how, and at what dose — physician decision based on evaluation — not upsold.
Transparent Pricing
Pricing principles:
• Transparent — all additional charges explained at evaluation
• No coerced course packages — we don't require full payment for 6 sessions upfront
• No "limited-time offer" marketing — consistent with Taiwan medical advertising regulations
Risks and Side Effects
9.1 Shockwave
• Common: transient treatment-site soreness, mild skin redness
• Rare: subcutaneous capillary rupture (bruising)
• Very rare: no clearly reported serious adverse events
9.2 PRP Injection
• Common: transient injection-site pain, pinpoint bleeding, bruising
• Occasional: local swelling at injection site for 1–2 days
• Very rare: allergic reaction, infection (under strict sterile operation)
9.3 Shared Contraindications
Already listed in Section 5. If any contraindication is found at evaluation, we decline the procedure and recommend alternatives — we don't take risks for revenue.
Ten Commonly Asked Questions
Q1. Does shockwave hurt?
Most describe it as "achy or tingling" — intensity is adjusted to tolerance by the physician. Individual experience varies.
Q2. Does PRP hurt?
Local anesthesia + buffering technique reduces sharp pain; a 27G needle can still cause transient discomfort or bruising.
Q3. How many sessions are needed?
Shockwave commonly uses 6 sessions as a baseline (weekly or biweekly). PRP count is physician-judged — not upsold.
Q4. How long do effects last?
Outcomes vary individually; not permanent. Track with IIEF-5 — no specific duration is promised.
Q5. Does it affect fertility?
Current literature shows no clear impact. Inform us at evaluation if planning a pregnancy.
Q6. When can I exercise or have sex after treatment?
Generally avoid vigorous exercise and sexual activity for 24–72 hours — follow clinic-specific post-treatment instructions.
Q7. Is it suitable for vasculogenic or psychogenic ED?
EAU lists LI-SWT as an option for mild vasculogenic ED (weak recommendation). Psychogenic ED requires additional interventions.
Q8. Can I book without giving my real name?
You can ask 3 anonymous questions via LINE. On-site visits still require minimum identification and medical records to comply with regulations.
Q9. Can my partner consult with me?
Yes. We offer a "joint partner consultation" option — it helps both sides understand the treatment content and expectations.
Q10. Does higher energy mean better results?
No. Current evidence does not support that claim. Our logic is "comfort → complete the protocol"; parameters are physician-adjusted within safety limits and your comfort.
Conclusion: Process as the Anchor, Evidence as the Boundary
The male intimate regeneration field has two extremes — on one side, the avoidance that causes delayed care; on the other, the overclaims of aggressive marketing. Liusmed Clinic chooses the middle path — trading process quality for trust, and evidence limitations for honesty.
Treatment-room clear, low-discomfort PRP, complete-the-protocol — these three pillars don't constitute an efficacy promise; they form a service protocol that is executable, verifiable, and optimizable. As for efficacy itself — your body and research evidence decide that together.
If you have any questions or want to learn more, you can ask 3 anonymous questions via LINE. We won't record your real name until you decide to book an in-person evaluation.
References
Salonia A, et al. EAU Guidelines on Sexual and Reproductive Health — Erectile Dysfunction. European Association of Urology, 2024. https://uroweb.org/guidelines/sexual-and-reproductive-health
Campbell JD, et al. Systematic review of low-intensity extracorporeal shock wave therapy for erectile dysfunction. Translational Andrology and Urology, 2019. PMID: 31807437
Chung E, Wang J. A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction. Expert Review of Medical Devices, 2021. PMID: 33583307
EDACT (Taiwan Erectile Dysfunction Diagnosis and Counseling Center) — prevalence and care-seeking statistics.
Medical Disclaimer
This article is for health education reference only and does not replace physician evaluation. All treatment decisions should rest on individual physician assessment, informed consent, and shared decision-making. Outcomes vary individually and no specific result can be guaranteed.